Indication

Moderate persistent asthma

Moderate persistent asthma is a clinical severity classification of chronic asthma, an inflammatory disorder of the lower respiratory tract affecting both pediatric and adult populations. Read more about Moderate persistent asthma

6 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Moderate persistent asthma therapies.

Showing 1–6 of 6 drugs

XOLAIR (omalizumab)

MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE)·CHRONIC IDIOPATHIC URTICARIA·+4
GENENTECH

DUPIXENT (dupilumab)

ECZEMA AGENTS SYSTEMIC INTERLEUKIN-4 (IL-4RA)ANTAG.MCAB·ATOPIC DERMATITIS·+10
Sanofi-Aventis U.S.

XOLAIR (omalizumab)

MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE)·CHRONIC IDIOPATHIC URTICARIA·+4
GENENTECH

DUPIXENT PEN (dupilumab)

ECZEMA AGENTS SYSTEMIC INTERLEUKIN-4 (IL-4RA)ANTAG.MCAB·ATOPIC DERMATITIS·+10
Sanofi-Aventis U.S.
Filter & compare in the drug finder →Opens the drug finder with Moderate persistent asthma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Moderate persistent asthma.

Moderate persistent asthma is a clinical severity classification of chronic asthma, an inflammatory disorder of the lower respiratory tract affecting both pediatric and adult populations.

Pathophysiologically characterized by airway hyperresponsiveness, chronic bronchial wall inflammation, and reversible airflow obstruction, it presents with daily symptoms such as wheezing, dyspnea, chest tightness, and cough.

Clinically, this stage is defined by daily rescue inhaler use, nighttime awakenings occurring more than once per week, and some degree of limitation in normal daily activity.

Objective pulmonary function testing typically demonstrates a forced expiratory volume in one second (FEV1) or peak expiratory flow between 60% and 80% of predicted values, alongside a reduced FEV1/FVC ratio.

Personalize your experience

Follow Moderate persistent asthma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it